pubmed-article:20331733 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20331733 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20331733 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
pubmed-article:20331733 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20331733 | lifeskim:mentions | umls-concept:C0024501 | lld:lifeskim |
pubmed-article:20331733 | lifeskim:mentions | umls-concept:C0026764 | lld:lifeskim |
pubmed-article:20331733 | lifeskim:mentions | umls-concept:C1282910 | lld:lifeskim |
pubmed-article:20331733 | lifeskim:mentions | umls-concept:C0444956 | lld:lifeskim |
pubmed-article:20331733 | lifeskim:mentions | umls-concept:C1831743 | lld:lifeskim |
pubmed-article:20331733 | lifeskim:mentions | umls-concept:C1515568 | lld:lifeskim |
pubmed-article:20331733 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:20331733 | pubmed:dateCreated | 2010-6-29 | lld:pubmed |
pubmed-article:20331733 | pubmed:abstractText | With the aim to address the issue whether high-dose therapy (HDT) is required after new drugs combinations to improve outcome of elderly newly diagnosed multiple myeloma (MM) patients, we compared the toxicity and the outcome of ThaDD plus maintenance to those of ThaDD plus HDT-autologous stem cell transplantation (ASCT). | lld:pubmed |
pubmed-article:20331733 | pubmed:language | eng | lld:pubmed |
pubmed-article:20331733 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20331733 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20331733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20331733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20331733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20331733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20331733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20331733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20331733 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20331733 | pubmed:month | Jun | lld:pubmed |
pubmed-article:20331733 | pubmed:issn | 1600-0609 | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:VisaniGiusepp... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:LeoniPietroP | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:GalieniPieroP | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:OffidaniMassi... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:CorvattaLaura... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:BurattiniMaur... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:MontanariMaur... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:BrunoriMarino... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:CenturioniRic... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:FalcioniSadia... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:CatariniMassi... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:AlesianiFranc... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:PolloniClaudi... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:FraticelliPao... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:GentiliSilvia... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:SamoriArduino... | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:SaviniAgneseA | lld:pubmed |
pubmed-article:20331733 | pubmed:author | pubmed-author:RuggieriMiria... | lld:pubmed |
pubmed-article:20331733 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20331733 | pubmed:volume | 84 | lld:pubmed |
pubmed-article:20331733 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20331733 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20331733 | pubmed:pagination | 474-83 | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:meshHeading | pubmed-meshheading:20331733... | lld:pubmed |
pubmed-article:20331733 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20331733 | pubmed:articleTitle | ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma. | lld:pubmed |
pubmed-article:20331733 | pubmed:affiliation | Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona. m.offidani@ospedaliriuniti.marche.it | lld:pubmed |
pubmed-article:20331733 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20331733 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |